Search Results - Axel Erenmalm

  • Showing 1 - 1 results of 1
Refine Results
  1. 1

    P106: Dose intensive brentuximab vedotin for platinum resistant recurrent Hodgkin lymphoma is a feasible treatment option - a single center experience by Axel Erenmalm, Johan Linderoth

    Published in HemaSphere (2022-10-01)
    Get full text
    Article


Search Tools: